TY - JOUR
T1 - Robot-assisted laparoscopic debulking surgery for recurrent adult granulosa cell tumors
AU - Groeneweg, Jolijn W
AU - Roze, Joline F
AU - Veldhuis, Wouter B
AU - Ruurda, Jelle P
AU - Gerestein, Cornelis G
AU - Zweemer, Ronald P
N1 - Funding Information:
We wish to thank the Granulosa Foundation Philine van Esch for providing financial support for this research.
Publisher Copyright:
© 2021
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
Funding Information:
We wish to thank the Granulosa Foundation Philine van Esch for providing financial support for this research.
Publisher Copyright:
© 2021
PY - 2021/8
Y1 - 2021/8
N2 - Despite an often early diagnosis and effective initial surgical management, one third of adult granulosa cell tumors (aGCTs) eventually, and often repeatedly, recurs. Debulking surgery remains the preferred treatment modality for recurrent aGCT, although the risk of intraoperative complications increases with repeated laparotomy. Minimally invasive surgery may limit the risk of complications. We aim to share our initial experience with robotic debulking surgery for recurrent aGCT. Clinical and surgical data of patients with recurrent aGCT who underwent robotic cytoreductive surgery over a three-year period at a tertiary referral center were retrospectively collected and analyzed. Between 2017 and 2020, three patients underwent robotic debulking surgery for recurrent aGCT at our institution. Complete cytoreduction was achieved in all patients. No intraoperative or postoperative complications were reported. This small pilot series at a single academic institution suggests that robot-assisted laparoscopy may be feasible and safe in selected patients with recurrent aGCT. A minimally invasive approach could reduce the complexity of successive surgeries for aGCT relapse.
AB - Despite an often early diagnosis and effective initial surgical management, one third of adult granulosa cell tumors (aGCTs) eventually, and often repeatedly, recurs. Debulking surgery remains the preferred treatment modality for recurrent aGCT, although the risk of intraoperative complications increases with repeated laparotomy. Minimally invasive surgery may limit the risk of complications. We aim to share our initial experience with robotic debulking surgery for recurrent aGCT. Clinical and surgical data of patients with recurrent aGCT who underwent robotic cytoreductive surgery over a three-year period at a tertiary referral center were retrospectively collected and analyzed. Between 2017 and 2020, three patients underwent robotic debulking surgery for recurrent aGCT at our institution. Complete cytoreduction was achieved in all patients. No intraoperative or postoperative complications were reported. This small pilot series at a single academic institution suggests that robot-assisted laparoscopy may be feasible and safe in selected patients with recurrent aGCT. A minimally invasive approach could reduce the complexity of successive surgeries for aGCT relapse.
KW - Cytoreductive surgery
KW - Debulking
KW - Granulosa cell tumor
KW - Recurrence
KW - Robot-assisted laparoscopy
UR - http://www.scopus.com/inward/record.url?scp=85105821162&partnerID=8YFLogxK
U2 - 10.1016/j.gore.2021.100783
DO - 10.1016/j.gore.2021.100783
M3 - Article
C2 - 34041344
SN - 2352-5789
VL - 37
JO - Gynecologic oncology reports
JF - Gynecologic oncology reports
M1 - 100783
ER -